NCT03235362View on ClinicalTrials.gov

A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 7, 2017

Primary Completion Date

September 19, 2017

Study Completion Date

September 19, 2017

Conditions
DyslipidemiaType 2 Diabetes Mellitus
Interventions
DRUG

YHR1705

Subjects will receive multiple oral doses of YHR1705 QD for 5 consecutive days in each period.

DRUG

YHR1706

Subjects will receive multiple oral doses of YHR1706 QD for 5 consecutive days in each period.

DRUG

YHR1705+YHR1706

Subjects will receive multiple oral doses of YHR1705 + YHR1706 QD for 5 consecutive days in each period.

Trial Locations (1)

Unknown

Chonbuk National University Hospital, Jeonju

All Listed Sponsors
lead

Yuhan Corporation

INDUSTRY

NCT03235362 - A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706 | Biotech Hunter | Biotech Hunter